BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

982 related articles for article (PubMed ID: 23370576)

  • 1. Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes.
    Bonofiglio D; Santoro A; Martello E; Vizza D; Rovito D; Cappello AR; Barone I; Giordano C; Panza S; Catalano S; Iacobazzi V; Dolce V; Andò S
    Biochim Biophys Acta; 2013 Jun; 1831(6):1027-36. PubMed ID: 23370576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The DLK gene is a transcriptional target of PPARγ.
    Couture JP; Blouin R
    Biochem J; 2011 Aug; 438(1):93-101. PubMed ID: 21585338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Citrate carrier promoter is target of peroxisome proliferator-activated receptor alpha and gamma in hepatocytes and adipocytes.
    Damiano F; Gnoni GV; Siculella L
    Int J Biochem Cell Biol; 2012 Apr; 44(4):659-68. PubMed ID: 22249025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor gamma inhibits follicular and anaplastic thyroid carcinoma cells growth by upregulating p21Cip1/WAF1 gene in a Sp1-dependent manner.
    Bonofiglio D; Qi H; Gabriele S; Catalano S; Aquila S; Belmonte M; Andò S
    Endocr Relat Cancer; 2008 Jun; 15(2):545-57. PubMed ID: 18509005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor gamma regulates expression of the anti-lipolytic G-protein-coupled receptor 81 (GPR81/Gpr81).
    Jeninga EH; Bugge A; Nielsen R; Kersten S; Hamers N; Dani C; Wabitsch M; Berger R; Stunnenberg HG; Mandrup S; Kalkhoven E
    J Biol Chem; 2009 Sep; 284(39):26385-93. PubMed ID: 19633298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anandamide induced PPARgamma transcriptional activation and 3T3-L1 preadipocyte differentiation.
    Bouaboula M; Hilairet S; Marchand J; Fajas L; Le Fur G; Casellas P
    Eur J Pharmacol; 2005 Jul; 517(3):174-81. PubMed ID: 15987634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisome proliferator-activated receptor-gamma transcriptionally up-regulates hormone-sensitive lipase via the involvement of specificity protein-1.
    Deng T; Shan S; Li PP; Shen ZF; Lu XP; Cheng J; Ning ZQ
    Endocrinology; 2006 Feb; 147(2):875-84. PubMed ID: 16269451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists.
    Costa V; Foti D; Paonessa F; Chiefari E; Palaia L; Brunetti G; Gulletta E; Fusco A; Brunetti A
    Endocr Relat Cancer; 2008 Mar; 15(1):325-35. PubMed ID: 18310298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small heterodimer partner-interacting leucine zipper protein inhibits adipogenesis by regulating peroxisome proliferator-activated receptor γ activity.
    Jang H; Kim HJ; Kim DH; Park JK; Sun WS; Hwang S; Oh KB; Jang WG; Lee JW
    Life Sci; 2015 Jul; 132():49-54. PubMed ID: 25896661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ATF3 represses PPARγ expression and inhibits adipocyte differentiation.
    Jang MK; Jung MH
    Biochem Biophys Res Commun; 2014 Nov; 454(1):58-64. PubMed ID: 25445599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very long-chain-fatty acids enhance adipogenesis through coregulation of Elovl3 and PPARγ in 3T3-L1 cells.
    Kobayashi T; Fujimori K
    Am J Physiol Endocrinol Metab; 2012 Jun; 302(12):E1461-71. PubMed ID: 22436697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A selective peroxisome proliferator-activated receptor gamma modulator with distinct fat cell regulation properties.
    Fujimura T; Kimura C; Oe T; Takata Y; Sakuma H; Aramori I; Mutoh S
    J Pharmacol Exp Ther; 2006 Aug; 318(2):863-71. PubMed ID: 16682454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.
    Yu C; Markan K; Temple KA; Deplewski D; Brady MJ; Cohen RN
    J Biol Chem; 2005 Apr; 280(14):13600-5. PubMed ID: 15691842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter.
    Zuo Y; Qiang L; Farmer SR
    J Biol Chem; 2006 Mar; 281(12):7960-7. PubMed ID: 16431920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sp1 mediates repression of the resistin gene by PPARgamma agonists in 3T3-L1 adipocytes.
    Chung SS; Choi HH; Cho YM; Lee HK; Park KS
    Biochem Biophys Res Commun; 2006 Sep; 348(1):253-8. PubMed ID: 16876120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation.
    Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT
    Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated transcriptional control of adipocyte triglyceride lipase (
    Roy D; Farabaugh KT; Wu J; Charrier A; Smas C; Hatzoglou M; Thirumurugan K; Buchner DA
    J Biol Chem; 2017 Sep; 292(36):14827-14835. PubMed ID: 28726642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of HOX gene expression and regulation in adipocyte development.
    Kumar V; Sekar M; Sarkar P; Acharya KK; Thirumurugan K
    Gene; 2021 Feb; 768():145308. PubMed ID: 33197517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling.
    Moyers JS; Shiyanova TL; Mehrbod F; Dunbar JD; Noblitt TW; Otto KA; Reifel-Miller A; Kharitonenkov A
    J Cell Physiol; 2007 Jan; 210(1):1-6. PubMed ID: 17063460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, Fyn.
    Woeller CF; O'Loughlin CW; Pollock SJ; Thatcher TH; Feldon SE; Phipps RP
    FASEB J; 2015 Mar; 29(3):920-31. PubMed ID: 25416548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.